Skip to main content
. 2017 Aug 10;8(43):75427–75433. doi: 10.18632/oncotarget.20130

Table 2. The association between LINC00152 and clinicopathological parameters.

Test of association Heterogeneity
OR/HR (95% CI) P Value I2 (%) P Value
Age 0.79 (0.55–1.14) 0.21 0 0.53
Gender 1.08 (0.74–1.58) 0.70 0 0.76
Lymph node metastasis 2.54 (1.54–4.18) 0.0003 37 0.16
TNM stage 2.32 (1.36–3.93) 0.002 52 0.04
Tumor recurrence 3.32 (1.98–5.57) < 0.00001 0 0.45
OS 1.94 (1.25–3.02) 0.003 50 0.11

OS, overall survival; HR, hazard ratio; OR, odds ratio; CI, confidence interval.